Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1994-01-13
1996-03-19
Gupta, Yogendra N.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514261, 514262, 544264, 544265, 544269, A61K 3152, C07D47334
Patent
active
055004288
ABSTRACT:
Compounds of formula I, and pharmaceutically acceptable salts thereof, ##STR1## in which R1 is hydrogen (1-6C)alkyl or (1-4C)alkanoyl; A is --N.dbd.CQ--O--, N.dbd.CQ--NR.sup.8 --, --N.dbd.CQ--CH.dbd.N--or --N.dbd.CH--CQ.dbd.N--;
REFERENCES:
patent: 2807616 (1957-09-01), Falco et al.
Hassan et al, Carbohydrate Research 34, pp. 203-207, 1974.
H. S. El Khadem and R. Sindric, "Synthesis of a 8-(hydroxyalkyl)adenines*",Carbohydrate Research, May 1974, vol. 34, No. 1, pp. 203-207.
Sato and Saito, "Studies on Pyrazines. 17. [1]. An Efficient Synthesis of Pteridine-6-Carboxylic Acids," J. Heterocyclic Chem., vol. 25, 1988, pp. 1737-1740.
"Furterene," The Merck Index, 11th Ed., published by Merck and Co., Rahway, New Jersey, 1989, p. 675, entry 4224.
Temple et al., "Synthesis of Potential Antimalarial Agents. VII. Azaquinolines. I. The Preparation of Some Pteridines and Pyrido [3,4-b] pyrazines (1)," J. Heterocyclic Chem., vol. 7, Oct. 1970, pp. 1195-1202.
Block Michael H.
Hargreaves Rodney B.
Harrison Alison
Gupta Yogendra N.
Imperial Chemical Industries plc
LandOfFree
Furyl-substituted purines and adenosine antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Furyl-substituted purines and adenosine antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Furyl-substituted purines and adenosine antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1959475